Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
The American Journal of Gastroenterology|September 7, 2012
Assessment of the quality of evidence underlying international guidelines in liver diseaseIan A Rowe, Richard Parker, Matthew J Armstrong, et al.Journal of Viral Hepatitis|October 20, 2018
Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapyArash Vaziri, Alexander Gimson, Kosh Agarwal, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2008
Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]Stephen Barclay, Stanislas Pol, David Mutimer, et al.Antiviral Therapy|November 13, 2004
Management of antiviral resistance in patients with chronic hepatitis BStephen Locarnini, Angelos Hatzakis, Jenny Heathcote, et al.Blood|October 8, 2008
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cellsZania Stamataki, Claire Shannon-Lowe, Jean Shaw, et al.Journal of Viral Hepatitis|September 15, 2025
Peer-Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and Treatment Among Unhoused PeopleGabriele Vojt, Philippe Bonnet, Jennifer Scott, et al.The Journal of Antimicrobial Chemotherapy|October 31, 2003
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantationJohn Philpott-Howard, Andrew Burroughs, Neil Fisher, et al.BMJ Open|August 7, 2019
Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysisLaure Lacoin, Michael Hurst, Nathan R Hill, et al.European Journal of Gastroenterology & Hepatology|June 22, 2011
Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapseDania Shoeb, Ian A Rowe, Dennis Freshwater, et al.Alimentary Pharmacology & Therapeutics|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completedKathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, et al.Pageof 5